Lv42
438 积分 2025-06-08 加入
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
17小时前
已完结
Benchmarking Large Language Models in Evidence-Based Medicine
1个月前
已完结
Integrative therapy for lower limb venous thrombosis in patients with COPD: a trial of Rhodiola rosea polyglucoside and pulmonary rehabilitation as a synergistic combination
2个月前
已关闭
EzPAP therapy versus non-invasive ventilation for hypercapnic chronic obstructive pulmonary disease exacerbation: a randomized clinical trial
2个月前
已关闭
Patient Factors and Clinical Efficacy of Early Identification and Treatment of Chronic Obstructive Pulmonary Disease and Asthma
2个月前
已完结
The impact of blood pressure variability on cardiovascular and renal outcomes in patients with and without diabetes: insights from the Anglo-Scandinavian Cardiac Outcomes Trial
2个月前
已关闭
Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
2个月前
已完结
Systematic Reviews of Prediction Models
4个月前
已完结
Novel AI applications in systematic review: GPT-4 assisted data extraction, analysis, review of bias
5个月前
已完结
Genetics of Human Primary Hypertension: Focus on Hormonal Mechanisms
6个月前
已完结
皖公网安备34019202002308
